The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
The newly launched protocol will accelerate the clinical development of stenoparib and its drug-specific Drug Response Predictor (DRP) companion diagnostic (CDx) toward potential FDA approval
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
Investment demonstrates confidence in America’s commitment to science and innovation
The transaction is expected to be completed by May 15, 2025 or such other date as may be mutually agreed
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
The new facility combines advanced technology, enhanced capacity, and holistic care, reaffirming HCG’s commitment to accessible, world-class oncology in Gujarat
Genomics is transforming the future of modern medicine and treatment modalities across specialties
More than 40 types of Amyloid proteins are discovered till date
Subscribe To Our Newsletter & Stay Updated
